Virios Therapeutics, Inc. VIRI
0.16 0.00 (+0.00%)
At closeOct 8, 2024, 4:00 PM EDT
0.143 Day range 0.2068
52-week range unavailable
News
defenseworld.net Analyzing Virios Therapeutics (NASDAQ:VIRI) & Palatin Technologies (PINK:PTNT) Virios Therapeutics (NASDAQ: VIRI - Get Free Report) and Palatin Technologies (PINK: PTNT - Get Free Report) are both small-cap medical companies, but which is the better business? We will compare…
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session - benzinga.com Why DocuSign Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
globenewswire.com Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”) ATLANTA and VANCOUVER, British Columbia, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (NASDAQ: VIRI) (the “Company”), and Wex Pharmaceuticals, Inc. (“WEX”), a wholly owned subsidiary…
globenewswire.com Virios Therapeutics Announces Second Quarter 2024 Financial Results - Bateman Horne Center completed enrollment in its groundbreaking investigator-initiated Long-COVID phase 2a study featuring valacyclovir and celecoxib (IMC-2) -
globenewswire.com Virios Therapeutics to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 ATLANTA, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat…
globenewswire.com Virios Therapeutics Announces Completion of Enrollment in IMC-2 Phase 2 Long-COVID Study Being Conducted by Bateman Horne Center - Virios projects releasing top line results from this groundbreaking Proof of Concept study in October 2024 - - Published data indicates increased Epstein-Barr herpes virus in Long-COVID patients,…
benzinga.com Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session - benzinga.com Why Chuy's Holdings Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket
benzinga.com Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket 
benzinga.com Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session 
globenewswire.com Virios Therapeutics Announces Closing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study ATLANTA, May 22, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company” or “Virios Therapeutics”), a development-stage biotechnology company focused on advancing novel…
benzinga.com Dow Falls Over 150 Points; Sohu Posts Q1 Loss - benzinga.com Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session 
https://www.benzinga.com US Stocks Mixed; Li Auto Shares Plummet After Q1 Results U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 0.5% on Monday. Following the market opening Monday, the Dow traded down 0.19% to 39,925.91 while the NASDAQ rose 0.50%…- benzinga.com US Stocks Mixed; Li Auto Shares Plummet After Q1 Results
investorplace.com Why Is Virios Therapeutics (VIRI) Stock Down 44% Today? Virios Therapeutics (NASDAQ: VIRI ) stock is falling on Monday after the development-stage biotechnology company announced the pricing of a public offering for its shares. Virios Therapeutics is…
benzinga.com Why Wix.com Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
globenewswire.com Virios Therapeutics Announces Pricing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study ATLANTA, May 19, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company” or “Virios Therapeutics”), a development-stage biotechnology company focused on advancing novel…
globenewswire.com Virios Therapeutics Announces Proposed Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study ATLANTA, May 17, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company” or “Virios Therapeutics”), a development-stage biotechnology company focused on advancing novel…
seekingalpha.com Virios Therapeutics, Inc. (VIRI) Q1 2024 Earnings Call Transcript Virios Therapeutics, Inc. (NASDAQ:VIRI ) Q1 2024 Earnings Conference Call May 9, 2024 8:30 AM ET Company Participants Angela Walsh - Senior Vice President of Finance, Secretary & Treasurer Greg…
globenewswire.com Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update - Top-line results from the ongoing investigator-initiated Bateman Horne Center Long-COVID phase 2 featuring valacyclovir and celecoxib (IMC-2) expected in the second-half of 2024 -
globenewswire.com Virios Therapeutics to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 ATLANTA, May 02, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session 
globenewswire.com Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID - New patent would extend coverage and expand potential value of Virios' antiviral pipeline globally – - Active Long-COVID characterized by immune dysfunction leading to recurrent herpesviruses…- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
globenewswire.com Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results ATLANTA, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat…
globenewswire.com Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones ATLANTA, Ga., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to…- benzinga.com Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session Shares of CommScope Holding Company, Inc. (NASDAQ: COMM) fell sharply during Monday’s session. B of A Securities analyst Tal Liani downgraded CommScope from Neutral to Underperform and lowered the…
- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
globenewswire.com Virios Therapeutics Announces Plans to Advance Development of IMC-2 as Treatment for Symptoms Associated with Long-COVID - Placebo-Controlled Clinical Proof of Concept Data Expected in Mid-2024 - - Targeting Initiation of IMC-2 Phase 2 program in 2H 2024 -- benzinga.com Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session.
globenewswire.com Virios Therapeutics, Inc. Reaches Alignment with FDA on Requirements for Advancing Development Candidate IMC-2 as Treatment for Long-COVID ATLANTA, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on developing novel antiviral therapies to treat…
seekingalpha.com Virios Therapeutics, Inc. (VIRI) Q3 2023 Earnings Call Transcript Virios Therapeutics, Inc. (NASDAQ:VIRI ) Q3 2023 Earnings Conference Call November 13, 2023 8:30 AM ET Company Participants Greg Duncan - CEO Angela Walsh - SVP, Finance & Treasurer Mike Gendreau -…
globenewswire.com Virios Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update - Conference Call Today at 8:30 a.m. ET - ATLANTA, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on…
benzinga.com Earnings Scheduled For November 13, 2023 Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.- benzinga.com Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results.
- benzinga.com Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders.
- benzinga.com Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session Gainers Amyris, Inc. (NASDAQ: AMRS) shares jumped 179.1% to $0.1839. Amyris shares dipped over 80% on Thursday after the company announced it filed for Chapter 11 bankruptcy.
- benzinga.com Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results.
- benzinga.com Earnings Scheduled For August 10, 2023 Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
- benzinga.com Earnings Scheduled For May 11, 2023 Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its…
- benzinga.com Dow Dips Over 300 Points; McDonald's Beats Q1 Expectations U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 300 points on Tuesday. The Dow traded down 0.92% to 33,562.53 while the NASDAQ fell 1.75% to 11,826.47. The S&P…
- benzinga.com Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Gainers
- benzinga.com Top 5 Health Care Stocks That May Fall Off A Cliff This Quarter The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
- benzinga.com Why Kura Sushi Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 104% to $5.55 after the company announced it has been selected by the U.S. Department of Defense for a position on the multiple award Indefinite…
- benzinga.com Why Chicken Soup For The Soul Entertainment Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket Gainers RiceBran Technologies (NASDAQ: RIBT) gained 43.1% to $1.33 in pre-market trading after gaining 3% on Tuesday.
- benzinga.com Earnings Scheduled For March 14, 2023 Companies Reporting Before The Bell • Super Group (SGHC) (NYSE:SGHC) is projected to report quarterly earnings at $0.07 per share on revenue of $314.67 million.